Clinical Trials Logo

Clinical Trial Summary

Non-interventional study to evaluate the utility of removing Dysplastic Nevi with a defined 2 mm margin.


Clinical Trial Description

This is a prospective, observational study to evaluate the utility of removing Dysplastic Nevi (DN) with a defined 2 mm margin. This is a non-interventional study that will observe the pathology results following a standard of care biopsy. Principal Investigator (PI) hypothesize that the majority of lesions removed with this technique will have margins free of nevus cells on examination of histopathological sections. Hence, pathologists will not suggest that an additional excision be performed to remove any residual nevus. PI also hypothesize that if biopsy sites are followed over time, the rate of nevus recurrence will be low, because investigators would have removed the majority, if not all of the lesion at the time of initial biopsy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03094273
Study type Observational
Source New York University School of Medicine
Contact
Status Completed
Phase
Start date February 25, 2013
Completion date March 2016

See also
  Status Clinical Trial Phase
Completed NCT00339222 - Family Study of Melanoma in Italy
Recruiting NCT05446155 - BioMEL- Diagnostic and Prognostic Factors in Melanoma.
Completed NCT00710489 - Potential Research Study Participant Registry
Recruiting NCT03362138 - Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions